USANA Health Sciences, Inc.
USNA
$17.05
-$0.09-0.52%
NYSE
| 01/03/2026 | 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/28/2024 | |
|---|---|---|---|---|---|
| Net Income | 72.78% | -167.55% | 2.69% | 111.09% | -58.01% |
| Total Depreciation and Amortization | 7.52% | -0.39% | -6.26% | 74.12% | 5.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.89% | 330.87% | -148.11% | 462.66% | -80.14% |
| Change in Net Operating Assets | -66.28% | -144.25% | 52.89% | -72.68% | -164.01% |
| Cash from Operations | -72.87% | -116.05% | -21.08% | 167.62% | -80.41% |
| Capital Expenditure | 12.60% | 36.38% | -79.34% | -55.55% | 24.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 180.69% | -- | -- |
| Cash from Investing | 134.71% | 23.16% | -7.41% | 98.11% | -8,674.08% |
| Total Debt Issued | -- | -100.00% | -- | -- | 1,150,000.00% |
| Total Debt Repaid | -- | 100.00% | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 44.00% | 99.34% | -5.28% | -19,450.00% | 6.33% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 44.14% | -131.93% | -- | -- | -- |
| Cash from Financing | 1,474.16% | 97.46% | -166.88% | -163.09% | 29,497.44% |
| Foreign Exchange rate Adjustments | 1,060.00% | -92.87% | 221.70% | 110.56% | -225.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 319.10% | 78.85% | -1,219.06% | 98.83% | -662.65% |